Advertisement

Topics

X4 Pharmaceuticals Presents Clinical Data Demonstrating Immune Activation Through CXCR4 Pathway ...

04:06 EST 10 Nov 2017 | BioMedReports - Blog

Supportive preclinical data show substantial single agent activity of CXCR4 inhibition in aggressive model of melanoma

Read more...

Original Article: X4 Pharmaceuticals Presents Clinical Data Demonstrating Immune Activation Through CXCR4 Pathway ...

NEXT ARTICLE

More From BioPortfolio on "X4 Pharmaceuticals Presents Clinical Data Demonstrating Immune Activation Through CXCR4 Pathway ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Melanoma
Melanoma is a highly malignant tumor of melanin-forming cells (melanocytes) There are most commonly found in the skin (resulting from sunlight exposure), but also in the eyes and mucous membranes. Metastasis to other regions of the body is also common....